Cargando…
Serum S100B in primary progressive multiple sclerosis patients treated with interferon-beta-1a
S100B belongs to a family of calcium-binding proteins implicated in intracellular and extracellular regulatory activities. This study of serum S100B in primary progressive multiple sclerosis (PPMS) is based on data obtained from a randomized, controlled trial of Interferon β-1a in subjects with PPMS...
Autores principales: | Lim, Ee Tuan, Petzold, Axel, Leary, Siobhan M, Altmann, Daniel R, Keir, Geoff, Thompson, Ed J, Miller, David H, Thompson, Alan J, Giovannoni, Gavin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC524502/ https://www.ncbi.nlm.nih.gov/pubmed/15482599 http://dx.doi.org/10.1186/1477-5751-3-4 |
Ejemplares similares
-
Beta-interferons in multiple sclerosis
por: Aggarwal, Sourabh, et al.
Publicado: (2010) -
Phosphorylation and compactness of neurofilaments in multiple sclerosis: Indicators of axonal pathology()
por: Petzold, Axel, et al.
Publicado: (2008) -
Progression in multiple sclerosis is associated with low endogenous NCAM
por: Gnanapavan, Sharmilee, et al.
Publicado: (2013) -
Multiple Sclerosis and Its Treatment
por: Giovannoni, Gavin, et al.
Publicado: (1999) -
Interferon Beta Activity Is Modulated via Binding of Specific S100 Proteins
por: Kazakov, Alexey S., et al.
Publicado: (2020)